Hospital News
Return to Chemotherapy Overview
More on Chemotherapy
- Update on Lymphoma Drug Trial:Potential Breakthrough for T-Cell Lymphoma Patients With Drug That Mimics a Vitamin
- NewYork-Presbyterian Hospital/Columbia University Medical Center Fertility Experts Present the Latest Research at Reproductive Medicine Meeting
- Nutrition Advice for Cancer Patients and Survivors Available in New DVD
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at American Society of Clinical Oncology 44th Annual Meeting
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Latest Cancer Findings at American Society of Clinical Oncology (ASCO) Meeting
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Columbia University Medical Center Launches Vaccine Trial For Previously Untreated Metastatic Colorectal Cancer Patients
- COX-2 Inhibitor May Boost Cancer Treatment, NewYork Weill Cornell Study Shows
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Weill Cornell Researchers Announce New Gene Therapy Strategy To Promote Hair Growth
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
Clinical Services
Return to Chemotherapy Overview
More on Chemotherapy
- Bladder Cancer
- Brain Cancer
- Cancer (Oncology)
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Eye Cancer
- Food and Nutrition
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Lung Cancer
- Mesothelioma
- Pediatric Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
Chemotherapy
What is chemotherapy?
Chemotherapy is the use of powerful, anti-cancer drugs to kill cancer cells. Often, it is not the primary therapy for prostate cancer patients, but may be used when prostate cancer has spread outside of the prostate gland, or in combination with other therapies.
According to the American Cancer Society, chemotherapy is not effective against early prostate cancer. Although it may slow tumor growth and reduce pain, it has had limited success for the treatment of advanced disease.
How is chemotherapy administered?
The anti-cancer drugs are given to patients either intravenously (injected into a vein), by mouth, or by injection. The drugs kill or cause damage to cancer cells, but may also damage normal cells. Hospitalization may be needed to monitor treatment and to control chemotherapy's side effects.
What are the most common side effects of chemotherapy?
Common side effects of chemotherapy depend on the type of drug used, the dosage, and the length of treatment, and may include the following:
- nausea and vomiting
- hair loss
- anemia
- reduced ability of blood to clot
- mouth sores
- increased likelihood of developing infections
- fatigue
Side effects, and the degree to which they are experienced, differ. Most side effects disappear once treatment is stopped.
Hospital News
- Update on Lymphoma Drug Trial:Potential Breakthrough for T-Cell Lymphoma Patients With Drug That Mimics a Vitamin
- NewYork-Presbyterian Hospital/Columbia University Medical Center Fertility Experts Present the Latest Research at Reproductive Medicine Meeting
- Nutrition Advice for Cancer Patients and Survivors Available in New DVD More
